1. Key statistics for lung cancer
2. Cancer statistics, 2022;Siegel RL,2022
3. SEER cancer statistics review, 1975–2015
4. Lung cancer survival rates
5. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou C,2011